BARCLAYS PLC - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 156 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$18,881
+226.6%
281,094
+235.7%
0.01%
+200.0%
Q2 2023$5,781
-46.4%
83,737
-62.5%
0.00%
-20.0%
Q1 2023$10,779
-57.1%
223,538
-55.6%
0.01%
-58.3%
Q4 2022$25,123
-99.8%
503,254
+67.1%
0.01%
-7.7%
Q3 2022$12,289,000
-23.7%
301,212
+2.8%
0.01%
+30.0%
Q2 2022$16,111,000
+80.7%
292,912
+19.4%
0.01%
+42.9%
Q1 2022$8,915,000245,3260.01%
Other shareholders
LEGEND BIOTECH CORP shareholders Q2 2022
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders